Insufficient scRNA-seq data for expression of GPATCH3 at single-cell level.
Insufficient scRNA-seq data for expression of GPATCH3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 682.74 | 1445 / 1445 | 100% | 11.14 | 183 / 183 |
| liver | 100% | 495.66 | 226 / 226 | 100% | 18.91 | 406 / 406 |
| skin | 100% | 951.10 | 1809 / 1809 | 100% | 29.38 | 472 / 472 |
| thymus | 100% | 693.95 | 653 / 653 | 100% | 25.32 | 605 / 605 |
| uterus | 100% | 752.38 | 170 / 170 | 100% | 26.78 | 459 / 459 |
| brain | 100% | 644.81 | 2639 / 2642 | 100% | 27.08 | 705 / 705 |
| lung | 100% | 626.73 | 576 / 578 | 100% | 18.44 | 1154 / 1155 |
| kidney | 100% | 607.47 | 89 / 89 | 99% | 16.46 | 896 / 901 |
| prostate | 100% | 710.98 | 245 / 245 | 99% | 20.20 | 499 / 502 |
| intestine | 100% | 741.85 | 966 / 966 | 99% | 16.23 | 523 / 527 |
| bladder | 100% | 727.71 | 21 / 21 | 99% | 21.33 | 500 / 504 |
| breast | 100% | 753.39 | 459 / 459 | 99% | 20.45 | 1109 / 1118 |
| pancreas | 99% | 377.63 | 325 / 328 | 100% | 19.22 | 178 / 178 |
| ovary | 100% | 562.74 | 180 / 180 | 99% | 12.95 | 426 / 430 |
| stomach | 100% | 623.14 | 359 / 359 | 98% | 13.50 | 280 / 286 |
| adrenal gland | 100% | 890.02 | 258 / 258 | 97% | 15.51 | 224 / 230 |
| adipose | 100% | 696.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 28.03 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 29.40 | 29 / 29 |
| muscle | 100% | 910.54 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 985.68 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 26.93 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.98 | 1 / 1 |
| blood vessel | 100% | 567.37 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 401.20 | 846 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 604.84 | 912 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032480 | Biological process | negative regulation of type I interferon production |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0039536 | Biological process | negative regulation of RIG-I signaling pathway |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | GPATCH3 |
| Protein name | G-patch domain containing 3 G patch domain-containing protein 3 |
| Synonyms | GPATC3 |
| Description | FUNCTION: Involved in transcriptional regulation. It is able to activate transcription from the CXCR4 promoter and therefore it might control neural crest cell migration involved in ocular and craniofacial development . Is a negative regulator of immune antiviral response, acting via down-regulation of RIG-I-like receptors signaling and inhibition of type I interferon production. The control mechanism involves interaction with mitochondrial MAVS and inhibition of MAVS assembly with downstream proteins implicated in antiviral response, such as TBK1 and TRAF6 . . |
| Accessions | ENST00000450844.1 ENST00000361720.10 ENST00000445019.5 H0Y5H5 Q5JYG5 Q96I76 |